AAAAAA
Results:
1-22
|
Results: 22
Authors:
Dash, A
Gilliland, DG
Citation: A. Dash et Dg. Gilliland, Molecular genetics of acute myeloid leukaemia, BEST P R C, 14(1), 2001, pp. 49-64
Authors:
Gilliland, DG
Citation: Dg. Gilliland, The diverse role of the ETS family of transcription factors in cancer - Commentary re: B. Davidson, Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma. Clin. Cancer Res., 7 : 551-557, 2001., CLIN CANC R, 7(3), 2001, pp. 451-453
Authors:
Gilliland, DG
Citation: Dg. Gilliland, Editorial commentary - Hematologic malignancies, CURR OPIN H, 8(4), 2001, pp. 189-191
Authors:
Frantsve, J
Schwaller, J
Sternberg, DW
Kutok, J
Gilliland, DG
Citation: J. Frantsve et al., Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation, MOL CELL B, 21(10), 2001, pp. 3547-3557
Authors:
Andreasson, P
Schwaller, J
Anastasiadou, E
Aster, J
Gilliland, DG
Citation: P. Andreasson et al., The expression of ETV6/CBFA2 (TEL/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologicdisease in vivo, CANC GENET, 130(2), 2001, pp. 93-104
Authors:
Sternberg, DW
Tomasson, MH
Carroll, M
Curley, DP
Barker, G
Caprio, M
Wilbanks, A
Kazlauskas, A
Gilliland, DG
Citation: Dw. Sternberg et al., The TEL/PDGF beta R fusion in chronic myelomonocytic leukemia signals through STAT5-dependent and STAT5-independent pathways, BLOOD, 98(12), 2001, pp. 3390-3397
Authors:
Okuda, K
Weisberg, E
Gilliland, DG
Griffin, JD
Citation: K. Okuda et al., ARG tyrosine kinase activity is inhibited by ST1571, BLOOD, 97(8), 2001, pp. 2440-2448
Authors:
Tomasson, MH
Williams, IR
Li, SG
Kutok, J
Cain, D
Gillessen, S
Dranoff, G
Van Etten, RA
Gilliland, DG
Citation: Mh. Tomasson et al., Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factoror interleukin-3, BLOOD, 97(5), 2001, pp. 1435-1441
Authors:
Li, SG
Gillessen, S
Tomasson, MH
Dranoff, G
Gilliland, DG
Van Etten, RA
Citation: Sg. Li et al., Interleukin 3 and granulocyte-macrophage colony-stimulating factor are notrequired for induction of chronic myeloid leukemia-like myeloproliferativedisease in mice by BCR/ABL, BLOOD, 97(5), 2001, pp. 1442-1450
Authors:
Schwaller, J
Anastasiadou, E
Cain, D
Kutok, J
Wojiski, S
Williams, IR
LaStarza, R
Crescenzi, B
Sternberg, DW
Andreasson, P
Schiavo, R
Siena, S
Mecucci, C
Gilliland, DG
Citation: J. Schwaller et al., H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22), BLOOD, 97(12), 2001, pp. 3910-3918
Authors:
Schwaller, J
Parganas, E
Wang, DM
Cain, D
Aster, JC
Williams, IR
Lee, CK
Gerthner, R
Kitamura, T
Frantsve, J
Anastasiadou, E
Loh, ML
Levy, DE
Ihle, JN
Gilliland, DG
Citation: J. Schwaller et al., Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2, MOL CELL, 6(3), 2000, pp. 693-704
Authors:
Levy, DE
Gilliland, DG
Citation: De. Levy et Dg. Gilliland, Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice, ONCOGENE, 19(21), 2000, pp. 2505-2510
Authors:
Wilbanks, AM
Mahajan, S
Frank, DA
Druker, BJ
Gilliland, DG
Carroll, M
Citation: Am. Wilbanks et al., TEL/PDGF beta R fusion protein activates STAT1 and STAT5: A common mechanism for transformation by tyrosine kinase fusion proteins, EXP HEMATOL, 28(5), 2000, pp. 584-593
Authors:
Liu, Q
Schwaller, J
Kutok, J
Cain, D
Aster, JC
Williams, IR
Gilliland, DG
Citation: Q. Liu et al., Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia, EMBO J, 19(8), 2000, pp. 1827-1838
Authors:
Loh, ML
Samson, Y
Motte, E
Moreau, LA
Dalton, V
Waters, S
Sallan, SE
Gilliland, DG
Citation: Ml. Loh et al., Translocation (2;8)(p12;q24) associated with a cryptic t(12;21)(p13;q22) TEL/AML1 gene rearrangement in a child with acute lymphoblastic leukemia, CANC GENET, 122(2), 2000, pp. 79-82
Authors:
Tomasson, MH
Sternberg, DW
Williams, IR
Carroll, M
Cain, D
Aster, JC
Ilaria, RL
Van Etten, RA
Gilliland, DG
Citation: Mh. Tomasson et al., Fatal myeloproliferation, induced in mice by TEL/PDGF beta R expression, depends on PDGF beta R tyrosines 579/581, J CLIN INV, 105(4), 2000, pp. 423-432
Authors:
Thompson, JA
Gilliland, DG
Prchal, JT
Bennett, JM
Larholt, K
Nelson, RA
Rose, EH
Dugan, MH
Citation: Ja. Thompson et al., Effect of recombinant human erythropoietin combined with granulocyte/macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome, BLOOD, 95(4), 2000, pp. 1175-1179
Authors:
Song, WJ
Sullivan, MG
Legare, RD
Hutchings, S
Tan, XL
Kufrin, D
Ratajczak, J
Resende, IC
Haworth, C
Hock, R
Loh, M
Felix, C
Roy, DC
Busque, L
Kurnit, D
Willman, C
Gewirtz, AM
Speck, NA
Bushweller, JH
Li, FP
Gardiner, K
Poncz, M
Maris, JM
Gilliland, DG
Citation: Wj. Song et al., Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia, NAT GENET, 23(2), 1999, pp. 166-175
Authors:
Ross, TS
Gilliland, DG
Citation: Ts. Ross et Dg. Gilliland, Transforming properties of the Huntingtin interacting protein 1/platelet-derived growth factor beta receptor fusion protein, J BIOL CHEM, 274(32), 1999, pp. 22328-22336
Authors:
Loh, ML
Silverman, LB
Neuberg, D
Sallan, SE
Gilliland, DG
Citation: Ml. Loh et al., TEL-AML1 fusion in relapsed childhood acute lymphoblastic leukemia - Response, BLOOD, 94(1), 1999, pp. 375-376
Authors:
Tomasson, MH
Williams, IR
Hasserjian, R
Udomsakdi, C
McGrath, SM
Schwaller, J
Druker, B
Gilliland, DG
Citation: Mh. Tomasson et al., TEL/PDGF beta R induces hematologic malignancies in mice that respond to aspecific tyrosine kinase inhibitor, BLOOD, 93(5), 1999, pp. 1707-1714
Authors:
Loh, ML
Silverman, LB
Young, ML
Neuberg, D
Golub, TR
Sallan, SE
Gilliland, DG
Citation: Ml. Loh et al., Incidence of TEL/AML1 fusion in children with relapsed acute lymphoblasticleukemia, BLOOD, 92(12), 1998, pp. 4792-4797
Risultati:
1-22
|